Navigation Links
Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment

at although, clinical trials need to be conducted as soon as possible to help alleviate the suffering of the increasing number of Alzheimer's patients, more research is still needed both to understand how amyloid beta proteins wreak havoc in the brain and to improve potential drugs.

Gouras and his colleagues are now trying to figure out how the protein clusters inside and outside the cells work together to destroy the cells. They already noticed that the clusters outside the cells affect those inside cells by making them grow. Another challenge will be to better understand what the clusters do inside the cells that lead to their death. The scientists are also using imaging and biochemical techniques to see, in cultured cells, how the antibodies affect the clusters.

"We have many indications that antibodies work. Now we need to understand how they do it," Gouras said.

The study appears in the June 29 issue of the Journal of Biological Chemistry.


'"/>




Page: 1 2 3

Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers reversed the process of memory loss
10. Researchers Identify Key Gene That May Help Brain Treatment
11. Researchers Discover Protein That Causes Malaria
Post Your Comments:
(Date:5/10/2008)...rganization Continues with Efforts to Gain Clearan...al Supplies, STAMFORD, Conn., May 10 /PRNewswire-...rt arrived in Myanmar earlier today to assess the,...in clearance for the,organization,s airlift of 15 ...o Yangon., "AmeriCares is working closely with th...
(Date:5/9/2008)...USTIN, Calif., May 9 /PRNewswire-FirstCall/ -- AMD... integrated specialty pharmaceutical company,with ...diary, Jade,Pharmaceutical Inc., today announced t...year ended December 31, 2007, which were included ...ecurities and Exchange,Commission on April 14, 200...
(Date:5/9/2008)...ANTA BARBARA, Calif., May 9 /PRNewswire-USNewsire/... and supplies to help victims of,the Cyclone Nargi...ner,Direct Relief International, to ensure that t... need it most., "It,s important to remember the c...at Myanmar starts with the people and organization...
(Date:5/9/2008)... Resolves Allegations of Compliance Matters at De.../ -- Leiner Health Products Inc.,("Leiner" or "the...,proposed agreement with the United States Departm...aware for approval. The proposed agreement would,r...erning the production,control and distribution of...
Breaking Medicine News(10 mins):Health News:AmeriCares Relief Worker Arrives in Myanmar 2Health News:AMDL Reports Going Concern Qualification 2Health News:Direct Relief's Corporate Partners Key to Aiding Cyclone Victims 2Health News:Leiner Health Products Submits Proposed Agreement with Department of Justice to U.S. Bankruptcy Court for Approval 2
...r urged vigilance on Thursday after tests on three... of the H5N1 strain of bird flu, which can be fata... flu pandemic as there has not been, for the momen...n from the H5N1 virus," Health Minister Roselyne B...
...cts African Americans than Caucasians ,this is due...g to a study published in the July 3, 2007, issue... Academy of Neurology. For the study, researchers...he cerebrospinal fluid of 66 African Americans to ...
...an abrupt end when a guest discovered bodies in th...Charrons wife Chantal, 46, and son Bryan 11. Th... clear up after a dinner with a group of friends T...n the city of Verviers, 78 miles east of Brussels,...
...at researchers hope will cast a lifeline to HIV pa... shown early promise in long-awaited trials, The L...ed TMC125, is designed as an alternative for patie...rugs called non-nucleoside reverse transcriptase i...
Other Medicine News:Health News:France Steps Up Vigilance After Bird Flu Outbreak 2Health News:Dinner Guest Recover Bodies in Freezer 2Health News:New "second-line" AIDS Drug Shows Promise in Trials 2
(Date:5/8/2008)...LEVELAND, May 8 /- DATATRAK...y and services company focused on global,eClinical... reported its,operating results for the first quar..., 2008, revenue decreased,approximately 41% to $2,...,233,000), or $(0.16) per share on both a basic an...
(Date:5/8/2008)...acy and safety data support potential of asenapine...a and bipolar I disorder, WASHINGTON, May 8 /PRNe...NYSE: SGP ) today announced that an overview of a...was presented at the 161st Annual Meeting of the,A...., May 3-8. Data from,the studies, involving patie...
(Date:5/8/2008)...EW HAVEN, Conn., May 8 /- V...nnounced the start of an investigator-sponsored,Ph...nt Cloretazine(R),(VNP40101M) in combination with ...reated acute myelogenous leukemia (AML) and high-r...being conducted under the,direction of Ellen K. Ri...
(Date:5/8/2008)...ILMINGTON, Del., May 8 /- A...ion of a supplemental New Drug Application,(sNDA) ... SEROQUEL XR(TM),(quetiapine fumarate) Extended-Re...f generalized anxiety disorder (GAD), including ma...ime approval has been sought for an,atypical antip...
Breaking Medicine Technology:DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 2Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 3AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 2AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 3AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 4AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 5AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 6AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 7AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 8Omega 3 Fatty Acids Protect the Spinal Cord Heart Brain and Eyes 15386 1Omega 3 Fatty Acids Protect the Spinal Cord Heart Brain and Eyes 15386 2Aerovance Secures 2420 Million in Debt Financing 4248 1Merck 26 Co Inc Named Keynote Sponsor For Diversity Alliance For Sciences Inaugural Conference 4246 1Merck 26 Co Inc Named Keynote Sponsor For Diversity Alliance For Sciences Inaugural Conference 4246 2Genaera Corporation Announces MSI 1436 Data Presented at Society of Neuroscience Meeting 1612 1Genaera Corporation Announces MSI 1436 Data Presented at Society of Neuroscience Meeting 1612 2Genaera Corporation Announces MSI 1436 Data Presented at Society of Neuroscience Meeting 1612 3Genaera Corporation Announces MSI 1436 Data Presented at Society of Neuroscience Meeting 1612 4
...al Findings Reported Safety & Tolerability Pro...Subjects --, CHICAGO, June 25, 2007 /PRNewswire-Fi...the annual meeting of the American Diabetes,Associ...of,dipeptidyl-peptidase-4 (DPP-4) in development b...n combination with metformin,exhibited a statisti...
... AV411,s Unique Mechanism of Action and Broad Pote... , ALAMEDA, Calif., June 26, 2007 (PRIME NEWSWIRE)...l company innovating therapeutics,for the treatmen...,Expert Opinion on Investigational Drugs has publi...t, AV411 (ibudilast), a potential,first-in-class, ...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 2Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 3Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 4Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 5
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
Medicine Products: